Literature DB >> 19246692

Mechanisms of C-reactive protein-induced blood-brain barrier disruption.

Christoph R W Kuhlmann1, Laura Librizzi, Dorothea Closhen, Thorsten Pflanzner, Volkmar Lessmann, Claus U Pietrzik, Marco de Curtis, Heiko J Luhmann.   

Abstract

BACKGROUND AND
PURPOSE: Increased mortality after stroke is associated with brain edema formation and high plasma levels of the acute phase reactant C-reactive protein (CRP). The aim of this study was to examine whether CRP directly affects blood-brain barrier stability and to analyze the underlying signaling pathways.
METHODS: We used a cell coculture model of the blood-brain barrier and the guinea pig isolated whole brain preparation.
RESULTS: We could show that CRP at clinically relevant concentrations (10 to 20 microg/mL) causes a disruption of the blood-brain barrier in both approaches. The results of our study further demonstrate CRP-induced activation of surface Fcgamma receptors CD16/32 followed by p38-mitogen-activated protein kinase-dependent reactive oxygen species formation by the NAD(P)H-oxidase. The resulting oxidative stress increased myosin light chain kinase activity leading to an activation of the contractile machinery. Blocking myosin light chain phosphorylation prevented the CRP-induced blood-brain barrier breakdown and the disruption of tight junctions.
CONCLUSIONS: Our data identify a previously unrecognized mechanism linking CRP and brain edema formation and present a signaling pathway that offers new sites of therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246692     DOI: 10.1161/STROKEAHA.108.535930

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  41 in total

1.  Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study.

Authors:  Marie Kim Wium-Andersen; David Dynnes Ørsted; Børge Grønne Nordestgaard
Journal:  Schizophr Bull       Date:  2013-08-31       Impact factor: 9.306

Review 2.  Myosin light chain kinase signaling in endothelial barrier dysfunction.

Authors:  Robert R Rigor; Qiang Shen; Christopher D Pivetti; Mack H Wu; Sarah Y Yuan
Journal:  Med Res Rev       Date:  2012-08-09       Impact factor: 12.944

3.  Retrospectively reported childhood physical abuse, systemic inflammation, and resting corticolimbic connectivity in midlife adults.

Authors:  Thomas E Kraynak; Anna L Marsland; Jamie L Hanson; Peter J Gianaros
Journal:  Brain Behav Immun       Date:  2019-08-22       Impact factor: 7.217

4.  Albumin causes increased myosin light chain kinase expression in astrocytes via p38 mitogen-activated protein kinase.

Authors:  Janet L Rossi; Hantamalala Ralay Ranaivo; Fatima Patel; Maryann Chrzaszcz; Charu Venkatesan; Mark S Wainwright
Journal:  J Neurosci Res       Date:  2011-02-24       Impact factor: 4.164

5.  Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes.

Authors:  Marcio Francisco Lehmann; Ana Paula Kallaur; Sayonara Rangel Oliveira; Daniela Frizon Alfieri; Franciele Delongui; Johnathan de Sousa Parreira; Maria Caroline Martins de Araújo; Carolina Rossato; Jéssica Tavares de Almeida; Larissa Moliterno Pelegrino; Erick Frank Bragato; Ana Lucia Cruz Fürstenberger Lehmann; Helena Kaminami Morimoto; Marcell Alysson Batisti Lozovoy; Andrea Name Colado Simão; Damácio Ramon Kaimen-Maciel; Edna Maria Vissoci Reiche
Journal:  Metab Brain Dis       Date:  2015-09-11       Impact factor: 3.584

6.  Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study.

Authors:  Eberhard Siebert; G Bohner; T Liebig; M Endres; T G Liman
Journal:  J Neurol       Date:  2016-11-04       Impact factor: 4.849

7.  Molecular correlates of spontaneous activity in non-human primates.

Authors:  Amanda C Mitchell; Georgina Aldridge; Shawn Kohler; Greg Stanton; Elinor Sullivan; Krassimira Garbett; Gabor Faludi; Károly Mirnics; Judy L Cameron; William Greenough
Journal:  J Neural Transm (Vienna)       Date:  2010-09-14       Impact factor: 3.575

8.  MicroRNAs in Cerebral Ischemia.

Authors:  Kai-Ying Lim; Jia-Hui Chua; Jun-Rong Tan; Priyadharshni Swaminathan; Sugunavathi Sepramaniam; Arunmozhiarasi Armugam; Peter Tsun-Hon Wong; Kandiah Jeyaseelan
Journal:  Transl Stroke Res       Date:  2010-12       Impact factor: 6.829

9.  CRP polymorphisms and DNA methylation of the AIM2 gene influence associations between trauma exposure, PTSD, and C-reactive protein.

Authors:  M W Miller; H Maniates; E J Wolf; M W Logue; S A Schichman; A Stone; W Milberg; R McGlinchey
Journal:  Brain Behav Immun       Date:  2017-09-01       Impact factor: 7.217

10.  Association of oxidative DNA damage and C-reactive protein in women at risk for cardiovascular disease.

Authors:  Nicole Noren Hooten; Ngozi Ejiogu; Alan B Zonderman; Michele K Evans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-13       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.